← Eichor
Study identifier: NCT07229014 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of a Collagen Supplement on Quality of Life, Appetite and Glycaemic Control

Condition: Quality of Life · Appetite · Sleep  ·  Sponsor: King's College London

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

This is a clinical trial aimed to investigate if a collagen supplement can improve quality of life, appetite and blood sugar in overweight and obese adults aged 18-65. Hypothesis: Consumption of a collagen supplement for 8 days will improve quality of life and improve glycaemic control in comparison with a placebo in individuals overweight or with obesity with a perceived low quality of life. Participants will be asked to: 1. Consume a collagen peptide supplement for a total of 8 days at a time 2. Fill in questionnaires about quality of life, appetite, mood and energy 3. Wear continuous glucose monitors

This description comes directly from the study's public registry record.

Talk to the study team

Alex Cheok, PhD  ·  +442078480313  ·  alex.cheok@kcl.ac.uk

Ana Rodriguez-Mateos, PhD  ·  ana.rodriguez-mateos@kcl.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Metabolic Research Unit (KCL, Waterloo Campus)London, London, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07229014